Supplementary Data — Hypochlorous Acid for COVID-19: real-time meta-analysis of 3 studies

@CovidAnalysis, October 2026, Version 1V1

.fp--anim .fp__study,.fp--anim .fp__sum,.fp--anim .fp__het,.fp--anim .fp__dia,.fp--anim .fp__verdict,.fp--anim .fp__pooled{opacity:1}.fp--anim .fp__ci{transform:none}.fp--anim .fp__pt{transform:translate(-50%,-50%)}.fp--anim .fp__plot::before{opacity:var(--shade-opacity)}.fp--anim-settle .fp__pt{left:calc(min(var(--pt),var(--max))/var(--max)*100%)}.fp--anim-settle .fp__ci,.fp--anim-settle .fp__dia{left:calc(var(--lo)/var(--max)*100%);width:calc((var(--hi) - var(--lo))/var(--max)*100%)}

October 2026

Hypochlorous acid COVID-19 outcomes

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk

Delgado-En.. (RCT)28%0.72 · 0.65–0.79recovery35 (n)104 (n) Delgado-En.. (RCT)34%0.66 · 0.59–0.75recovery35 (n)104 (n) Delgado-En.. (RCT)42%0.58 · 0.50–0.68recovery35 (n)104 (n) Delgado-En.. (RCT)38%0.62 · 0.54–0.71recovery35 (n)104 (n) Delgado-En.. (RCT)48%0.52 · 0.43–0.63recovery35 (n)104 (n) Delgado-En.. (RCT)45%0.55 · 0.47–0.66recovery35 (n)104 (n) Delgado-En.. (RCT)51%0.49 · 0.39–0.60recovery35 (n)104 (n) Panatto (RCT)37%0.63 · 0.12–3.38progression2/203/19 Panatto (RCT)85%0.15 · 0.01–2.65progression0/183/19 Panatto (RCT)67%0.33 · 0.06–1.83progression2/383/19 Panatto (RCT)29%0.71 · 0.54–0.93viral+34 (n)15 (n) Panatto (RCT)30%0.70 · 0.56–0.88viral+34 (n)15 (n) Gutiérrez-G.. (RCT)91%0.09 · 0.01–0.72symp. case1/8410/79

00.511.52+

Rotate screen for more detailsIncrease width for more details

← Hypochlorous Acid
reduces riskHypochlorous Acid
increases risk →

Fig. S1. All outcomes.